Designing Better Medicines
Making drug development designable
Our goal is to make drug development a true design discipline — reducing trial-and-error so better medicines can reach patients faster and with greater confidence.
Generative drug design powered by patient-relevant testing
We combine de novo drug design with large-scale, human-relevant testing to turn trial-and-error discovery into designable, engineerable success.
By building and owning the data, AI, and integrated dry/wet-lab systems as one engine, we can design medicines with the properties patients need — binding, developability, cellular function, and in-vivo performance.
The result: New medicines that are safer, more precise, unlock new targets, and expand the frontier of how we understand, measure, and treat disease.
Partnering with the world's leading pharmaceutical companies
To maximize the impact of our platform, we are partnering with leading pharmaceutical companies to design drugs and bring them to patients.
